PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2129031
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2129031
Vertebroplasty And Kyphoplasty Needles Market size was valued at US$ 980.7 Million in 2025, expanding at a CAGR of 5.1% from 2026 to 2033.
Vertebroplasty and kyphoplasty needles are very unique, high-gauge percutaneous needles that have been specifically developed for the sole purpose of precisely delivering bone cement to the compressed vertebral bone and to inflate the balloon tamp via fluoroscopy and restoring the height of the vertebral bone and providing stability to it. The needle consists of two parts; each needle is made up of two parts called a radiopaque perforated outer cannula and a sharp bevelled trocar-style stylet, which are joined to make a handle for insertion and have depth markings on them. There is also a luer-lock port on the needle handle which offers a facility for cement delivery and balloon inflation under pressure.
Vertebroplasty And Kyphoplasty Needles Market- Market Dynamics
Rising Prevalence Of Osteoporosis To Drive Treatment Demand
Rising prevalence of osteoporosis will promote the need for efficient testing in laboratories and drug development in relation to osteoporosis, which will contribute towards better development of osteoporosis treatment therapies. For example, based on June 2025 information from the Royal Osteoporosis Society Org, musculoskeletal conditions, including osteoporosis, cause 15.5% of all days lost from work and are the main cause of sickness absence. It is additionally mentioned in the report that over 57,000 working-age adults suffer from osteoporotic fractures every year and that there are 1.5 million days of sickness per year due to osteoporosis-related fractures. It is estimated that there are 3.5 million osteoporosis patients in the UK who suffer 500,000 bone fractures every year. This growing disease burden is expected to increase demand for reliable laboratory testing and osteoporosis treatment research.
The Global Vertebroplasty And Kyphoplasty Needles Market is segmented on the basis of Procedure, End Use, Application, and Region.
Based on procedure, the kyphoplasty procedure segment holds a prominent share in the Vertebroplasty And Kyphoplasty Needles market. The application of these products is widespread in carrying out the minimally invasive procedures for vertebral compression fractures, including the procedure of spinal height restoration, pain relief and stabilisation, due to growing demand for the new technology of treating spinal fractures. In July 2025, Stryker launched another innovation in its portfolio of vertebroplasty procedures that include the vertebral needles for kyphoplasty procedures. These solutions are designed to support controlled vertebral access, procedural efficiency, and consistent clinical performance.
In the market for vertebroplasty and kyphoplasty needles, spinal tumours hold a significant share as one of its major contributors due to an elevated level of vertebra compression fractures because of osteoporosis and the increasing popularity of minimally invasive techniques in the treatment of chronic back pain and spine stabilisation. For example, in January 2026, the total number of 1,315 patients diagnosed with CNS and spinal tumours during a 5-year retrospective observational study carried out at Sawai Man Singh (SMS) Hospital in Jaipur, Rajasthan (NIH Gov.), included 116 cases (8.82%) of spinal tumours and 1,199 (91.2%) of all tumours diagnosed. The most prevalent diagnosis of the patients suffering from spinal tumours was meningioma (indicating the high prevalence rate of spinal tumours among other diagnoses). These trends are expected to support continued demand for minimally invasive spinal tumour treatment procedures.
Vertebroplasty And Kyphoplasty Needles Market- Geographical Insights
North America holds a notable share in the Vertebroplasty And Kyphoplasty Needles market because of an increase in the number of patients suffering from osteoporosis and vertebral fractures. The increasing need for minimally invasive spine treatments would fuel the growth of the market in the region. For instance, in October 2025, according to the American College of Surgeons (Org.), minimally invasive surgery (MIS) in the past 40 years since the introduction of laparoscopic surgery is now referred to as the gold standard in treatment in many high-volume procedures because laparoscopic surgery has become the gold standard in the treatment of many diseases. In addition, many robotic systems have experienced rapid growth, including multi-port robotic systems, which are in their fifth generation and are applied in the approach to surgery of such organs as the prostate, pancreas, and liver. These trends highlight growing demand for minimally invasive spinal interventions and specialized needle-based treatment solutions.
The competitive landscape of the vertebroplasty and kyphoplasty needle industry has changed as companies have started working on making these procedures safer, developing better needle features and finding more uses for them in minimally invasive spinal treatments. These changes have motivated major players of the market like Stryker Corporation, Medtronic, Inc., Merit Medical Systems, Inc., IZI Medical Products, Inc., and Cook Medical Inc. to increase their presence in the market through introducing new products and finding alternatives. In October 2025, ZAVATION introduced/updated information about the ZVPlasty System, which operates while performing a vertebroplasty procedure for gaining access to the vertebral body in the case of vertebral compression fractures in the thoracic and lumbar parts of the spine. These advancements are expected to support safer, more efficient, and increasingly precise spinal procedures.
In July 2026, IKA presented new-generation laboratory products equipped with smart connectivity and wireless sensor and device control technologies, thus reinforcing its technological portfolio for contemporary laboratory applications.